In addition to suggesting a novel mechanism of epileptogenesis in DS and potentially explaining altered antiepileptic efficacy in DS patients31, our results may impact the interpretation of previous Scn1a DS mouse model studies. This evidence concerns the gene SCN1A and Dravet syndrome.